Outbreak of Kyasanur Forest disease in Thirthahalli, Karnataka, India, 2014

Kyasanur Forest disease virus (KFDV) was first identified in 1957, when it was isolated from a sick monkey from the Kyasanur Forest in Karnataka State, India. Since then it has been reported to be enzootic in five districts of Karnataka State, India. Recent reports of human infections have reached a...

Full description

Bibliographic Details
Published in:	International Journal of Infectious Diseases
Main Authors:	Pragya D. Yadav, Anita M. Shete, Deepak Y. Patil, V.K. Sandhya, K.S. Prakash, Rajesh Surgihalli, Devendra T. Mourya
Format:	Article
Language:	English
Published:	Elsevier 2014-09-01
Subjects:	Kyasanur Forest disease Real-time RT-PCR IgM antibody Ticks Virus Monkey
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971214015410

Similar Items

Kyasanur Forest Disease in India: innovative options for intervention
by: Paramasivan Rajaiah
Published: (2019-10-01)

Kyasanur Forest Disease, India, 2011–2012
by: Gudadappa S. Kasabi, et al.
Published: (2013-02-01)

Identification of bio-climatic determinants and potential risk areas for Kyasanur forest disease in Southern India using MaxEnt modelling approach
by: Malay Pramanik, et al.
Published: (2021-12-01)

Descriptive epidemiology of Kyasanur forest disease in Thirthahalli taluk, Shivamogga, Karnataka, 2018–2022
by: Srividya K. Vedachalam, et al.
Published: (2025-04-01)

Kyasanur Forest Disease: Clinical manifestations and molecular dynamics in a zoonotic landscape
by: Amogh Verma, et al.
Published: (2024-01-01)

Construction of an immunoinformatics-based multi-epitope vaccine candidate targeting Kyasanur forest disease virus
by: Sunitha Manjari Kasibhatla, et al.
Published: (2025-03-01)

Historical Expansion of Kyasanur Forest Disease in India From 1957 to 2017: A Retrospective Analysis
by: S. Chakraborty, et al.
Published: (2019-02-01)

Study of the clinical manifestations and risk factors in people affected during the first Kyasanur Forest Disease outbreak in Goa, India: A mixed method study
by: Shubham Pai Kuchelkar, et al.
Published: (2024-01-01)

Kyasanur Forest Disease Virus: Epidemiological Insights, Pathogenesis, Therapeutic Strategies, and Advances in Vaccines and Diagnostics
by: Babita Bohra, et al.
Published: (2025-07-01)

Evaluation of Safety and Potency of Kyasanur Forest Disease (KFD) Vaccine Inactivated with Different Concentrations of Formalin and Comparative Evaluation of In Vitro and In Vivo Methods of Virus Titration in KFD Vaccine
by: Ullas Gowda K. Srikanth, et al.
Published: (2023-06-01)

Kyasanur Forest Disease Outbreak and Vaccination Strategy, Shimoga District, India, 2013–2014
by: S.K. Kiran, et al.
Published: (2015-01-01)

Immunoinformatic-based multi-epitope vaccine design and validation against Kyasanur forest disease: A tick-borne viral infection
by: Deepthi Adla, et al.
Published: (2025-07-01)

First evidence of transovarial transmission of Kyasanur Forest disease virus in Haemaphysalis and Rhipicephalus ticks in the wild
by: Sarah J. Burthe, et al.
Published: (2025-01-01)

Pathogenicity and virulence of Kyasanur Forest disease: A comprehensive review of an expanding zoonotic threat in southwestern India
by: Himanshu Kaushal, et al.
Published: (2025-12-01)

Computational Exploration of Potential Pharmacological Inhibitors Targeting the Envelope Protein of the Kyasanur Forest Disease Virus
by: Sharanappa Achappa, et al.
Published: (2024-07-01)

Assessment of Dengue and Chikungunya Infections among Febrile Patients Visiting Four Healthcare Centres in Yaoundé and Dizangué, Cameroon
by: Stella Mariette Nana-Ndjangwo, et al.
Published: (2022-09-01)

Exposure to ticks and seroprevalence of [i]Borrelia burgdorferi [/i]among a healthy young population living in the area of southern Podlasie, Poland
by: Anna Pańczuk, et al.
Published: (2014-09-01)

A Low Viral Dose in COVID-19 Patient: A Case Report
by: Yajuan Li, et al.
Published: (2020-06-01)

Persistence of scrub typhus IgM and IgG antibodies among patients from Karnataka, India
by: Kiran Chunduru, et al.
Published: (2025-12-01)

Anti-Tick-Bourne Encephalitis IgM Intrathecal Synthesis as a Prediction Marker in Tick-Borne Encephalitis Patients
by: Piotr Czupryna, et al.
Published: (2025-01-01)

Prevalence and Abundance of Ixodid Ticks in Domestic Mammals in Villages at the Forest Fringes of the Western Ghats, India
by: Hari Kishan Raju, et al.
Published: (2025-07-01)

Kyasanur Forest Disease: An Epidemiological Investigation and Case-Control Study in Shivamogga, Karnataka, India-2022
by: Srividya K. Vedachalam, et al.
Published: (2024-10-01)

Exploring phytochemicals as potential pharmacological inhibitors for NS1 protein of Kyasanur forest disease virus using virtual screening, molecular docking, and molecular simulation approach
by: Sharanappa Achappa, et al.
Published: (2025-10-01)

Teste imunoenzimático (ELISA) para detecção de anticorpos circulantes da classe IgM na leptospirose humana
by: Marcos Vinícius da Silva, et al.
Published: (1988-04-01)

Avaliação do teste ELISA-lgM no diagnóstico precoce da leptospirose humana Evaluation of IgM ELISA assay in the early diagnosis of human leptospirosis
by: Eide Dias Camargo, et al.
Published: (1992-08-01)

Hematological, inflammatory and serological responses among COVID-19 patients admitted to intensive care unit
by: Mirette A Morgan, et al.
Published: (2024-12-01)

Serological findings during a measles outbreak occurring in a population with vaccine coverage Achados sorológicos durante um surto de sarampo em uma população com alta cobertura vacinal
by: Solange A. Oliveira, et al.
Published: (1995-10-01)

Role of cycle threshold values in predicting poor outcomes in patients with Kyasanur Forest disease: a retrospective cohort study
by: Nitin Gupta, et al.
Published: (2025-12-01)

Role of biomarkers in predicting mortality in patients with flaviviral disease endemic to South India: a retrospective observational study
by: Nitin Gupta, et al.
Published: (2025-09-01)

Diagnosis of Dengue by Serology (NS-1 Antigen and IgM ELISA) and Identification of Serotypes by RT-PCR at a Tertiary Care Hospital, Jaipur, Rajasthan
by: Abhilasha Kumawat , SK Singh , Bharti Malhotra , Anita Lamba , Shikha Soni
Published: (2024-08-01)

Seroprevalence of antibodies IgG/IgM anti-T. gondii in women of Coro, Venezuela
by: Saúl-García Yotsabeth, et al.
Published: (2019-06-01)

IgM and IgA Antibody Responses in 12 Cases of Human Acquired Toxoplasmosis
by: Emília E. H. TAKAHASHI, et al.
Published: (1997-11-01)

Newly discovered and conserved role of IgM against viral infection in an early vertebrate
by: Weiguang Kong, et al.
Published: (2025-09-01)

Different Cross-Reactivities of IgM Responses in Dengue, Zika and Tick-Borne Encephalitis Virus Infections
by: Karin Stiasny, et al.
Published: (2021-03-01)

Autoantibodies in hospitalised patients with COVID‐19
by: Eleni Tiniakou, et al.
Published: (2024-01-01)

Multiple infections with hepatitis A virus and development of rheumatoid arthritis among waste water treatment plant workers
by: Dina Nadeem Abd-Elshafy, et al.
Published: (2022-01-01)

Emergence of travel: Associated dengue fever in a non-endemic, hilly state
by: Santwana Verma, et al.
Published: (2014-01-01)

Seroprevalence Of Leptospirosis in South Gujarat Region by Evaluating the Two Rapid Commercial Diagnostic Kits Against the Mat Test for Detection of Antibodies to Leptospira Interorgan
by: Tanvi Panwala, et al.
Published: (2011-06-01)

Endogenous complement-activating IgM is not required for primary antibody responses but promotes plasma cell differentiation and secondary antibody responses to a large particulate antigen in mice
by: Anna-Karin E. Palm, et al.
Published: (2024-01-01)

IgM nephropathy is a controversial entity: a distinct nephropathy or part of the podocytopathy spectrum? A systematic review of the literature
by: Seyda Gul Ozcan, et al.
Published: (2026-04-01)